Geneva, 8 June 2023 – A global observational study, which involved more than 3,200 newborn babies suffering from sepsis in 19 hospitals in 11 countries, … Global study highlights deaths from neonatal sepsis and steps to improve treatment
Gonorrhoea is among the three most common sexually transmitted infections, affecting men and women worldwide. Global infection rates of gonorrhoea are increasing, with 82 million … GARDP and Innoviva Specialty Therapeutics announce completion of patient recruitment for registrational phase 3 gonorrhoea treatment trial
Geneva, 22 May 2023 – The UK government has renewed its support to GARDP by investing an additional £5 million in 2023/2024 to help develop … UK Government invests £5 million in GARDP to boost antibiotic development and access
Geneva, 22 May 2023 – An international clinical trial to evaluate much-needed new antibiotic combinations for newborn babies with sepsis has started in three public … Groundbreaking clinical trial to improve treatment for newborns with life-threatening sepsis gets underway in South Africa and Kenya
Geneva, 19 May 2023 – Representatives from the European Commission’s Health Emergency Preparedness and Response Authority (HERA), WHO and GARDP met in Geneva on 11 May, … HERA, WHO and GARDP join forces to counter the growing threat of antimicrobial resistance
Geneva (Switzerland), Liverpool (United Kingdom), 9 March 2023 – The Global Antibiotic Research and Development Partnership (GARDP) and the University of Liverpool have signed … GARDP and the University of Liverpool plan to boost collaboration on AMR
ภาษาไทย Geneva (Switzerland), Bangkok (Thailand), 28 February 2023 – The Global Antibiotic Research and Development Partnership (GARDP) and Mahidol University by the Faculty of Medicine … GARDP and SICRES, part of the Faculty of Medicine Siriraj Hospital, Mahidol University, seek to strengthen clinical research for priority drug-resistant infections in Asia
プレスリリース（日本語） GENEVA AND OSAKA – The Global Antibiotic Research and Development Partnership (GARDP) and Mitsubishi Tanabe Pharma Corporation (MTPC) have signed an … GARDP and Mitsubishi Tanabe Pharma Corporation announce partnership in search for new antibiotics
プレスリリース（日本語） GENEVA AND OSAKA – The Global Antibiotic Research and Development Partnership (GARDP) and Sumitomo Pharma Co., Ltd (Sumitomo Pharma) have signed … GARDP and Sumitomo Pharma announce partnership in search for new antibiotics
Berlin, 17 October 2022 – The German Federal Ministry of Education and Research today announced an additional funding of EUR 50 million to support the … Germany and other funders pledge support to GARDP to ramp up efforts in countering antibiotic resistance